Investor Backing & Capital Strength:
Recent announcements cite a $30M Series B led by Andreessen Horowitz, bringing total funding to roughly $50M, which feedback suggests provides runway to hire, ship product, and expand through 2025–2026.
Market Expansion:
Company materials describe moving beyond its behavioral‑health wedge to support multiple care settings (pediatric, long‑term care, substance use, autism) and operating across many U.S. states, indicating a broadened commercial footprint.
Strategic Partnerships:
Publicized collaborations such as the Flychain integration are presented as strengthening financial operations for providers and extending distribution in core niches like ABA.
